Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers

Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers

IntroductionThe European Society for Medical Oncology (ESMO) 2021 Guidelines contraindicate the administration of chemotherapy in the last month of patients’ life. The main objective of this multicenter observational retrospective study was to calculate the time elapsed between the date of the last...

Full description

Saved in:
Bibliographic Details
Main Authors: Giulia Scotto, Anna Galatà, Robert Fruscio, Giulia Besana, Fabio Landoni, Luca Sgro, Alessandra Testi, Fulvio Borella, Gennaro Cormio, Mariangela Gianciotta, Francesca Arezzo, Brigida Anna Maiorano, Alessandra Baldoni, Marinella Destefanis, Jole Ventriglia, Sandro Pignata, Rita Chiari, Maria Carmen Azzolina, Ivano Raimondo, Margherita Turinetto, Valentina Tuninetti, Massimo Di Maio, Giorgio Valabrega
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
chemotherapy
end of life
quality of life
gynecologic cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1641758/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1641758/full

Similar Items